Cedars-Sinai Researchers Create Blood Test to Detect Early Stage Liver Cancer

September 19, 2022 by Dan McCue
Cedars-Sinai Researchers Create Blood Test to Detect Early Stage Liver Cancer
Dr. Ju Dong Yang, medical director of the Liver Cancer Program at Cedars-Sinai Medical Center.

LOS ANGELES — A team of investigators at Cedars-Sinai Medical Center have created a blood test that uses a technology made commonly available during the COVID-19 pandemic to detect the most common form of liver cancer — at an early enough stage that cure is possible. 

Their work was published online in the peer-reviewed journal Hepatology.

“This important work could fill an unmet need for a more user-friendly, more accurate screening test that detects liver cancer early and saves lives,” said Dr. Ju Dong Yang, medical director of the Liver Cancer Program at Cedars-Sinai in a written statement.

Hepatocellular carcinoma is the most common form of liver cancer and is usually undetectable until it reaches an advanced stage, when it is usually fatal.

It occurs mainly in people with scarring of the liver, called cirrhosis, or chronic hepatitis B infection. 

There are fewer than 200,000 cases per year in the U.S., but globally it is the third-leading cause of cancer death, and in some countries it is the most common cancer-related death.

Currently, the best available screening method for at-risk patients is ultrasound imaging of the liver. However, ultrasound testing can be expensive and time-consuming, putting it out of reach of many patients, and the tests often miss smaller, early stage tumors that could be curable.

“Most at-risk patients aren’t screened,” said Yang, corresponding author of the study. “They struggle to get insurance authorizations and contact the imaging center, and then show up to have the test done — and the test’s accuracy can be limited, particularly in patients with obesity or more advanced liver disease. This is where a screening blood test becomes increasingly valuable.”

The test pioneered by Yang and colleagues is a form of “liquid biopsy” that looks for evidence of cancer in blood specimens and uses polymerase chain reaction technology — the same technology used in some tests for COVID-19.

In this study, a phase 2 multi-center clinical trial, the team investigated a protein biomarker on the surface of extracellular vesicles, particles that cells use to communicate with each other and that circulate in the blood. The marker proved around 90% accurate in identifying patients with hepatocellular carcinoma. 

The test could prove especially lifesaving in parts of the world where imaging resources are limited. To date, no other liquid biopsy test for liver cancer has been evaluated rigorously enough for use in clinical practice, Yang said.

Dan can be reached at [email protected] and @DanMcCue


A+
a-
  • blood test
  • Cedars-Sinai Medical Center
  • liver cancer
  • In The News

    Health

    Voting

    Health

    Protecting Access to Hospitals Is Crucial for Rural America

    Maternal health care in rural America is in crisis. Declining birth rates and shrinking populations have played a role, but this crisis... Read More

    Maternal health care in rural America is in crisis. Declining birth rates and shrinking populations have played a role, but this crisis is more acute now than ever because of widespread hospital closures in rural areas. On top of that, the dozens of maternity ward closures happening across the country have... Read More

    September 20, 2023
    by Dan McCue
    Administration to Resume Offering Free At-Home Covid Tests

    WASHINGTON — Beginning Monday, Americans will once again be able to order free coronavirus tests from the U.S. government, the... Read More

    WASHINGTON — Beginning Monday, Americans will once again be able to order free coronavirus tests from the U.S. government, the Department of Health and Human Services said on Wednesday afternoon. The Biden administration said it is reviving a program it put on ice in May when... Read More

    September 20, 2023
    by TWN Staff
    DHS Homeland Security Investigations Releases Strategy to Combat Illicit Opioids

    WASHINGTON — The Department of Homeland Security’s Homeland Security Investigations on Tuesday released the Strategy for Combating Illicit Opioids, an... Read More

    WASHINGTON — The Department of Homeland Security’s Homeland Security Investigations on Tuesday released the Strategy for Combating Illicit Opioids, an intelligence-driven approach to disrupting and dismantling transnational criminal organizations and keeping dangerous substances, like illicit fentanyl driving the overdose epidemic, off America’s streets.  The strategy leverages... Read More

    September 12, 2023
    by Dan McCue
    FDA Advisory Panel Concludes OTC Decongestant Doesn’t Work

    WASHINGTON — A common decongestant ingredient used in many popular over-the-counter medications simply doesn’t work, an advisory panel to the... Read More

    WASHINGTON — A common decongestant ingredient used in many popular over-the-counter medications simply doesn’t work, an advisory panel to the Food and Drug Administration said Tuesday, potentially setting the stage for a sweeping removal of many cold and flu remedies from store shelves. The debate over... Read More

    September 12, 2023
    by Dan McCue
    Census Bureau Says US Poverty Rate Surged as Pandemic Aid Ended

    WASHINGTON — The nation’s poverty rate increased dramatically last year as inflation drove up the cost of living and federal... Read More

    WASHINGTON — The nation’s poverty rate increased dramatically last year as inflation drove up the cost of living and federal aid programs created to help families weather the coronavirus pandemic were allowed to expire, the Census Bureau said on Tuesday. The bad news came in three... Read More

    September 11, 2023
    by Dan McCue
    High Air Pollution Rates Found to Boost Breast Cancer Incidence

    WASHINGTON — People living in areas with high levels of particulate air pollution are likely to experience an increased incidence... Read More

    WASHINGTON — People living in areas with high levels of particulate air pollution are likely to experience an increased incidence of breast cancer, according to a new study conducted by National Institutes of Health researchers. Their work, published in the Journal of the National Cancer Institute,... Read More

    News From The Well
    scroll top